quantities (HAE type I), or a dysfunctional protein in normal or even excessive amounts (HAE type II). Previously, we have found strong association between baseline level of functional C1-inhibitor and severity of HAE. Our aim was to investigate complement activation products in HAE, during a follow-up period, and to analyze the relationship between these products and severity of disease. Methods: 107 HAE patients (96 HAE type I, 11 type II) and 113 healthy control subjects were included. C1rC1sC1-INH, C3bBbP, and SC5b-9 levels were determined using ELISA methods in single EDTA-plasma samples of controls and in 4 samples from patients taken in 4 subsequent years. Betweengroup differences were evaluated with the Mann-Whitney test, and correlations were calculated using non-parametric Spearman's correlation coefficients. Results: Median levels of C1rC1sC1-INH (60 U/mL Background: In HIV discordant couples (one parther is HIV-infected, another is HIV-uninfected) HIV-negative partners often remain uninfected for a long time despite long, stable, often unprotected sexual contacts with HIVinfected partner. The increase of time of living together accompanying the decrease of the incidence of HIV infection in HIV-negative partner. The features of HIV-specific immune response in HIV discorgant couples was investigated. Methods: Thirty-three HIV discordant couples from Moscow region living together ,1 year (2 couples), 1 to 3 years (18 couples), 4 to 5 years (9 couples), 6 to 10 years (4 couples) were included in the investigation. Sera of 33 HIVuninfected partners from HIV discordant couples (17 men and 16 women) were tested for HIV-specific antibodies by enzyme immunoassay and immunoblot. Viral load was estimated by polymerase chain reaction (PCR). Results: Antibodies against HIV gp160 were detected in 3 persons (9,1%), against p68/66din 3 persons (9,1%), against p52/51din 3 persons (9,1%), against g34/31din 3 persons (9,1%); totaldin 6 persons (18,2%). All of them were defined as HIV-uninfected by PCR. In 4 of 6 persons HIV-specific antibodies were not detected after finishing of risk behavior.
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Conclusions:
It is possible to suggest that detected antibodies against HIV gp160, p68/66, p52/51, p34/31 in HIV-uninfected people are caused by contact with HIV (according to literature data, non-specific stimulation may cause the appearance of antibodies binding the other HIV antigens: p55, p24/ 25 and g18) and may contribute to maintainance of HIV-negative status of uninfected partners in HIV-discordant couples. The cohort of high exposed but HIV-uninfected people was formed during immunological monitoring of HIV discordant couples in Moscow region. This cohort is available for systematic observation and is perspective for further investigation of mechanisms of resistance to HIV infection and correlates of immune protection. Now the cohort is expanded. Background: This study reports a case series of HIV-1-infected patients that had dengue infection during the outbreak in 2009 in Colima, Mexico and it analyzes the effect of the interaction in relation to the progression of HIV disease. Methods: Whole blood samples from 22 HIV-1-infected patients who were suspected to have dengue infection were analyzed. The diagnosis of dengue infection was confirmed through the detection of NS1 antigen using SD Bioline Dengue Duo Rapid Test. Dengue virus serotype was determined by RT-PCR technique. Amplicons were cloned and submitted for automated sequencing for both strands. Comparison of the sequences with all of those published in GenBank (NCBI) was done using Blast Software. Written informed consent was obtained under the protocol approved by the Ethical Review Committee of the Center for Biomedical Research, University of Colima. Results: We tested 22 whole blood samples from HIV-1-infected patients in our laboratory, and 7 were positive for Dengue virus type 1. Two strains of DEN1 were identified in these infections. The strains were DENV-1/MX/ BID-V3664/2006 (GenBank: GQ868499) and DENV-1/MX/BID-V3744/ 2008 (GenBank: GQ868529) with a similarity of 99% each. CD41 cells remained at normal levels and it was not observed an accelerated progression of HIV disease. Conclusions: This is the fifth and largest report dealing with a coinfection among HIV and Dengue virus in the world, and the first report documented in Mexico. The lack of complications associated with this interaction suggests that this combination is relatively benign. Little has been documented about the interaction among these pathogens and further research is needed to understand the biology of HIV reproduction in the context of coinfection with Dengue virus. Furthermore, this report supports the circulation of multiple genetic variations of DEN1 in hyperendemic areas which may complicate the epidemiological panorama of the disease in those areas.
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